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1. Introduction 
During pregnancy in higher animals and humans, 
riboflavin, is actively concentrated by the conceptus 
with resultant increase in foetahmaternal p asma ratio 
of the vitamin [ 1,2]. The underlying molecular pro- 
cesses, including the possible involvement of a spe- 
cific vitamin-carrier p otein in this phenomenon are 
hitherto unknown though the impermeability of the 
placental membranes to the free vitamin and its coen- 
zyme forms has been recognized [3]. In the chicken, 
on the other hand a reproduction-specific, high affinity 
carrier-protein mediates adequate deposition of ribo- 
flavin in the eggs for proper embryonic development 
and survival [4-61. Earlier, we had purified and 
developed aspecific radioimmunoassay (RIA) for this 
avian riboflavin-carrier p otein (RCP) to study the 
kinetics of its hormonal induction in estrogenised 
birds [6,7]. High specificity and potency of the anti- 
serum (a/s) employed therein prompted us to inves- 
tigate the probability of the pregnant rat elaborating 
a similar carrier-protein presumably for transplacental 
delivery of riboflavin to developing foetuses. We have 
shown that sera from pregnant rats, but not from 
adult male or immature animals, contain a protein 
species which crossreacts with the specific a/s to the 
chicken RCP [8,9]. Here we show that estrogen (E) 
induces this protein in the rat and that in vivo passive 
immunoneutralization f the protein terminates preg- 
nancy in this mammal. 
2. Materials and methods 
Inbred Wister ats, were fed a pelleted diet 
(Hindustan Lever Products, Bombay) and water ad 
Address correspondence to: Dr P. R. Ad& 
ElsevierlNorth-Holland Biomedical Press 
libitum. They were exposed to a 14 h: 10 h light-dark 
schedule. Adult female rats with regular 4day oestrous 
cycle were mated with adult males and the day on 
which sperms were detected in the vaginal smear was 
taken as day 1 of pregnancy. The number of implan- 
tation sites on uterine horns were counted by lapro- 
tomy on day 7. Sera prepared from blood withdrawn 
by cardiac puncture were used for RIA. The rabbit 
a/s to purified chicken RCP, ovalbumin and ovomucoid 
were prepared and characterized as detailed in [6,10]. 
RIA was carried out using 1251-labelled chicken RCP 
and its specific a/s [6] and the concentrations of
crossreacting protein in suitably diluted rat sera were 
quantified using this RIA and are expressed in terms 
of the chicken RCP used as standard. The sources of 
chemicals and other materials used were the same as 
in [6,7]. 
3. Results and discussion 
The data of fig. 1 substantiates the validity of the 
heterologous RIA method for quantification of the 
rat serum RCP since a good parallelism between stan- 
dard curves for dose-dependent displacement of 12’1- 
labelled antigen from its homologous antibody by the 
unlabelled chick RCP and the pregnant rat serum is 
clearly evident. 
It is clear from the results offig2A, that in the 
pregnant rat, significant amounts of the rat RCP are 
present as early as day 4 of gestation, i.e, even 
before implantation, suggesting that the protein is of 
materal origin. Following a measurable fall on day 7 
the concentrations of the specific protein markedly 
increase by day 10 with minor fluctuation in its levels 
thereafter tIlI day 18. It is significant that high concen- 
trations of the protein in circulation are more or less 
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Fig.1. Displacement of ‘*%labelled purified chicken ribofla- 
vin-carrier protein to its homologous a/s in the presence of 
varying amounts of (A) chicken riboflavin-carrier protein and 
(B) pregnant rat serum. The RIA and the competition experi- 
ments were performed as detailed in [6]. The dilution of the 
specific a/s was 1: 10 000 and the *ZJI-labelled chicken protein 
had spec. act. 6 X IO8 cpm/pg protein. 
maintained uring this critical period of rapid embry- 
onic growth and organogenesis [ 111. Assuming that, 
as in the chicken, circulatory E is the primary inducer 
of this reproduction-specific protein in the pregnant 
rat also, it would appear that the si~i~cantly elevated 
hormonal levels on day 4 and days 8- 10 of pregnancy 
[ 121 are responsible for this pattern of protein levels. 
A strict temporal relationship between the serum E 
concentrations and the specific protein may not be 
apparent presumably due to multiple hormonal inter- 
action during pregnancy. On the other hand, in cycling 
rats (fig.2B) a good correlation between serum con- 
centrations of the steroid and the specific protein is 
apparent with pro-estrous surge of E [ 121 coinciding 
with the maximum concentration of the specific pro- 
tein. The results obtained with ovarectomized females 
treated with estradiol-17~(E~) (fig3C) confirm this 
correlation in addition to demonstrating E involve- 
ment in induction phenomenon. Since the maximum 
levels are reached around day 4 following the hormone 
administration, it would appear that the effect of pro- 
estrous E surge manifests maximally during the next 
pro-estrous period in the cycling rat. Of relevance in 
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this context are the observations that in malnourished 
women taking combination contraceptive pills in some 
parts of the developing world riboflavin deficiency is 
aggrevated [13,14]. Since E appears to be the primary 
inducer of RCP in higher animals, it is conceivable 
that induction of this specific protein drains the 
vitamin from circulation consequent to binding to 
such carrier protein which has no normal physiological 
function except in pre~ancy. 
The importance of adequate circulatory concentra- 
tions of the specific protein for maintenance and pro- 
gression of pregnancy was revealed in experiments 
wherein endogenous protein was neutralized in vivo 
by administering adequate quantities of the potent 
and specific a/s to the chicken RCP (table 1). In the 
a/s treated animals, the effect on pregnancy was dra- 
matic; there was profuse vaginal bleeding within 
24-48 h followed by a 100% foetal rejection as con- 
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Fig.2. The concentrations of the crossreacting protein in the 
rat sera: (A) during pregnancy; (B) during rl-day estrous cycle; 
(C) in ovarectomized female following a single injection of 
estradiol-17p. The pregnant rats were housed in individual 
cages, and the serum concentrations of the protein determined 
by reference to the standard curve in the heterologous RIA 
(fig.1). The cycling rats of the same age and body wt. are 
used in (B). PE, proestrous; E, estrous; D, diestrous days of 
the cycle. The animals of similar age and body wt. were 
ovarectomized and after 8 days were injected with estradiol- 
170 intramuscularly (0.5 mg/lOO g body wt) and sera was 
analysed on subsequent days. Base line value prior to estrogen 
treatment, i.e., on day 0 was <6 ngfml serum. Vertical bars 
represent SD (n = 4). 
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Table 1 
The influence of the specific antiserum to the chicken riboflavin-carrier protein on pregnant rats 
Group No. of At laprotomy on Treatment Autopsy on Remarks 
animals day 8 WIT) day.18 
1 4 2819.3 
2 3 2119 
3 4 3919.1 
4 3 2819.3 
Non-immune 
rabbit serum 
Gvalbumin or 
ovomucoid a/s 
aJs to chicken ribo- 
flavin-carrier protein 
Riboflavincarrier pro- 
tein a/s neutralised 
2819.3 
2119 
o/o 
2819.3 
Normal 
No bleeding, 
viable pups 
Profuse bleeding 
during 24-48 h 
No bleeding, 
viable pups 
The pregnant rats (15 day, loo-150 g body wt) were treated with either the non-immune rabbit 
serum (0.5 ml), the a/s to ovalbumin or the a/s to the purified chicken riboflavincarrier protein raised 
in rabbits (0.2 ml/rat). nT = total number of implantation sites. T = average implantation sites/animal 
determined at laprotomy. The a/s to either ovalbumin or ovomucoid could neutralize 400 pg respective 
protein/ml of serum while the a/s to chicken riboflavin-binding protein had a corresponding potency 
of 300 fig/ml. The sera was administered intraperitonially 
firmed at autopsy. An identical pattern was observed, 
when the a/s was administered during the period from 
day 6- 16 of pregnancy; however, after day 18, the 
a/s had no perceptible effect on foetal survival; the 
reasons for this relative refractoriness are not clear at 
present. Interestingly, equivalent amounts of either 
non-immune rabbit serum, the a/s to ovalbumin and 
Fig.3. The relative sizes of uterine horns and inclusions dis- 
sected from pregnant rats which have been treated with (A) 
nonimmune rabbit serum (0.5 ml/rat) and (B) the rabbit a/s 
to the chicken riboflavin-carrier protein (0.2 ml/rat). The 
autopsy was performed at 24 h after intraperitonial serum 
administrations, i.e., at the beginning stages of vaginal bleeding. 
The a/s used neutralized 300 pg chicken riboflavin-carrier 
protein/ml at equivalence point. 
ovomucoid or the pre-neutralized a/s to the chicken 
riboflavin-binding protein, uniformly failed to induce 
either vaginal bleeding or abortion demonstrating the 
specificity of immunoneutralization. Autopsy of the 
animals treated with the a/s to the chicken RCP during 
the early periods of vaginal bleeding showed signifi- 
cant foetal wastage as gauged by the relative sizes of 
the foetal inclusions in the uterine horns (fig.3). Fur- 
ther, it has been consistently observed that the animals 
which abort following the a/s treatment appear normal 
and resume their regular 4 day estrous cycle indicating 
that the maternal wellbeing including endocrine func- 
tions is unaffected by the passive immunoneutraliza- 
tion of the reproduction specific protein. 
The above data clearly show that the pregnant rat 
sera contain a maternal protein, which is immunochem- 
ically similar to the chicken riboflavin-binding protein 
and functionally is of paramount importance for foetal 
wellbeing and progression of pregnancy. In agreement, 
this protein can be purified from the pregnant rat 
serum by affinity chromatography on lumiflavin- 
Sepharose [ 151 and binds [2-14C]riboflavin with high 
affmity (in preparation). Employing a similar 
approach, we have been able to isolate such a protein 
from the sera of pregnant monkeys, Macaca radiata 
(unpublished). Furthermore with the recent discovery 
of the thiamin-binding protein in the chicken and 
development of a specific a/s to it [ 16,171, we have 
shown the presence in the pregnant rat, of yet another 
specific protein crossreacting with this a/s [8]; more 
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importantly administration of this a/s to the pregnant 
rat also leads to profuse vaginal bleeding and foetal 
rejection in a manner identical to that described with 
the a/s to RCP [8]. 
Apart from showing for the first time the presence 
and functional importance of reproduction-specific 
RCP in mammalian embryonic development these 
observations have other important implications: 
(9 
(ii) 
They emphasize that in addition to the satisfac- 
tory maternal vitamin supply, adequate and effi- 
cient pregnancy-specific delivery systems (carrier 
protein) ultimately determine the foetal vitamin 
nutrition; 
A possible explanation for some of the ill-defined 
causes of premature foetal death and/or terato- 
genesis may lie in genetic or endocrine defects in 
the production and/or functionality of these 
carrier proteins. 
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